Purdue Pharma Products LP v. Par Pharmaceutical Inc.
1:07-cv-00666
Overview
Parties
Defendant
Par Pharmaceutical Inc. Operating Company
Represented By
1 Attorneys ListedRichards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Par Pharmaceutical Companies Inc. Operating Company
Represented By
1 Attorneys ListedRichards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Plaintiff
Ortho-McNeil Inc. Operating Company
Represented By
2 Attorneys ListedWomble Carlyle Sandridge Rice
Womble Carlyle Sandridge Rice, 222 Delaware Avenue
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Biovail Laboratories International SRL Operating Company
Represented By
2 Attorneys ListedBayard, P.A.
Bayard, P.A., 222 Delaware Avenue, Suite 900
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Purdue Pharma Products LP NPE (University / Research)
Represented By
1 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Napp Pharmaceutical Group Ltd. Operating Company
Represented By
1 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 11 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 6,254,887 B1 Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 7,074,430 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2006026960 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2009011719 | US Continuation / Sibling | View Official Patent → |
| π©πͺ Germany | DE 4315525 A | Germany Counterpart | View Official Patent → |
| π¬π§ United Kingdom | GB 9324045 A | United Kingdom Counterpart | View Official Patent → |
| π¬π§ United Kingdom | GB 2284760 B | United Kingdom Counterpart | View Official Patent → |
| π¬π§ United Kingdom | GB 9404544 A | United Kingdom Counterpart | View Official Patent → |
| π¬π§ United Kingdom | GB 9404928 | United Kingdom Counterpart | View Official Patent → |
| π¬π§ United Kingdom | GB 2287880 A | United Kingdom Counterpart | View Official Patent → |
| πΊπΈ United States | US 5,591,452 A | US Continuation / Sibling | View Official Patent → |
Purdue Pharma Products LP v. Anchen Pharmaceuticals Inc
Purdue Pharma Products LP v. Par Pharmaceuticals Inc.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6254887
Controlled release tramadol
|
Filed: 1996-07-10
Issued: 2001-07-03
|
Expired (Term Ended)
Expires: 2016-07-10
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
Standard Statutory Term β No obviousness-type double patenting truncation noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).